Accepted for/Published in: JMIR Cancer
Date Submitted: Jun 24, 2020
Date Accepted: Sep 30, 2020
Date Submitted to PubMed: Oct 7, 2020
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
The Impact of COVID-19 on Cancer-Screening: Challenges and Opportunities
ABSTRACT
Cancer is a leading cause of deaths in the U.S. and across the globe. Cancer screening is an effective preventive measure that can reduce cancer incidence and mortality. While cancer screening is integral to cancer control and prevention, due to the coronavirus outbreak many screenings have either been cancelled or postponed, leaving a vast number of patients without access to recommended healthcare services. This disruption to cancer screening services may have a significant impact on patients, healthcare practitioners, and health systems. In this article, we aim to offer a comprehensive view of the impact of COVID-19 on cancer screening. Specially, we present challenges COVID-19 exerted on patients, healthcare practitioners, and health systems as well as potential opportunities that could help address these challenges.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.